Skip to Main Content

Author Details

William J Britt
Heersink School of Medicine, University of Alabama at Birmingham
1979
269
74
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
34547210Let's lower the floor: Clinical utility of the D-KEFS TMT with a forensic psychiatric inpatient population.Appl Neuropsychol Adult2023
37806805Vaccine value profile for cytomegalovirus.Vaccine2023
36719764Murine cytomegalovirus reactivation concomitant with acute graft-versus-host disease is controlled by antibodies.JCI Insight2023
37058447SOX2 downregulation of PML increases HCMV gene expression and growth of glioma cells.PLoS Pathog2023
37515187SARS-CoV-2 Spike Protein Is Capable of Inducing Cell-Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies.Viruses2023
37494473Signatures of AAV-2 immunity are enriched in children with severe acute hepatitis of unknown etiology.Sci Transl Med2023
34547210Let's lower the floor: Clinical utility of the D-KEFS TMT with a forensic psychiatric inpatient population.Appl Neuropsychol Adult2023
37806805Vaccine value profile for cytomegalovirus.Vaccine2023
37515187SARS-CoV-2 Spike Protein Is Capable of Inducing Cell-Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies.Viruses2023
37494473Signatures of AAV-2 immunity are enriched in children with severe acute hepatitis of unknown etiology.Sci Transl Med2023
37058447SOX2 downregulation of PML increases HCMV gene expression and growth of glioma cells.PLoS Pathog2023
36719764Murine cytomegalovirus reactivation concomitant with acute graft-versus-host disease is controlled by antibodies.JCI Insight2023
31957489Decision making of forensic psychiatric inpatients deemed incompetent to stand trial.Appl Neuropsychol Adult2022
35765315Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies.Open Forum Infect Dis2022
35511732Acute Hepatitis and Adenovirus Infection Among Children - Alabama, October 2021-February 2022.MMWR Morb Mortal Wkly Rep2022
35830653A Case Series of Children with Acute Hepatitis and Human Adenovirus Infection.N Engl J Med2022
35876526Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.J Virol2022
35789534Acute hepatitis and adenovirus infection among children-Alabama, October 2021-February 2022.Am J Transplant2022
31957489Decision making of forensic psychiatric inpatients deemed incompetent to stand trial.Appl Neuropsychol Adult2022
35215877Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts.Viruses2022
35020472Human Cytomegalovirus Hijacks WD Repeat Domain 11 for Virion Assembly Compartment Formation and Virion Morphogenesis.J Virol2022
35014624A congenital CMV infection model for follow-up studies of neurodevelopmental disorders, neuroimaging abnormalities, and treatment.JCI Insight2022
35511732Acute Hepatitis and Adenovirus Infection Among Children - Alabama, October 2021-February 2022.MMWR Morb Mortal Wkly Rep2022
35765315Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies.Open Forum Infect Dis2022
35830653A Case Series of Children with Acute Hepatitis and Human Adenovirus Infection.N Engl J Med2022
35789534Acute hepatitis and adenovirus infection among children-Alabama, October 2021-February 2022.Am J Transplant2022
35876526Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.J Virol2022
35014624A congenital CMV infection model for follow-up studies of neurodevelopmental disorders, neuroimaging abnormalities, and treatment.JCI Insight2022
35215877Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts.Viruses2022
35020472Human Cytomegalovirus Hijacks WD Repeat Domain 11 for Virion Assembly Compartment Formation and Virion Morphogenesis.J Virol2022
32596725Comparing Nasopharyngeal and Midturbinate Nasal Swab Testing for the Identification of Severe Acute Respiratory Syndrome Coronavirus 2.Clin Infect Dis2021
33630019NK/ILC1 cells mediate neuroinflammation and brain pathology following congenital CMV infection.J Exp Med2021
34160252A Novel Strain-Specific Neutralizing Epitope on Glycoprotein H of Human Cytomegalovirus.J Virol2021
33622794Virological Characteristics of Hospitalized Children With SARS-CoV-2 Infection.Pediatrics2021
34200083Cytomegalovirus Infection and Inflammation in Developing Brain.Viruses2021
33504601Localization of the WD repeat-containing protein 5 to the Virion Assembly Compartment Facilitates Human Cytomegalovirus Assembly.J Virol2021
34193339Predictors of Nonseroconversion after SARS-CoV-2 Infection.Emerg Infect Dis2021
33555597Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.Methods Mol Biol2021
32884104Comprehensive evaluation of risk factors for neonatal hearing loss in a large Brazilian cohort.J Perinatol2021
32596725Comparing Nasopharyngeal and Midturbinate Nasal Swab Testing for the Identification of Severe Acute Respiratory Syndrome Coronavirus 2.Clin Infect Dis2021
35062219Human Cytomegalovirus Egress: Overcoming Barriers and Co-Opting Cellular Functions.Viruses2021
34451526Murine Models of Central Nervous System Disease following Congenital Human Cytomegalovirus Infections.Pathogens2021
34647593Coronavirus Disease 2019 and Children.J Infect Dis2021
35121884RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4<sup>+</sup> T-cell-dependent antitumor immunity.Nat Cancer2021
33630019NK/ILC1 cells mediate neuroinflammation and brain pathology following congenital CMV infection.J Exp Med2021
33622794Virological Characteristics of Hospitalized Children With SARS-CoV-2 Infection.Pediatrics2021
33504601Localization of the WD repeat-containing protein 5 to the Virion Assembly Compartment Facilitates Human Cytomegalovirus Assembly.J Virol2021
33555597Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.Methods Mol Biol2021
35121884RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4<sup>+</sup> T-cell-dependent antitumor immunity.Nat Cancer2021
35062219Human Cytomegalovirus Egress: Overcoming Barriers and Co-Opting Cellular Functions.Viruses2021
  • 1 - 50 of 538

Recommended Authors

Rockefeller University
Career Start Year 2011
Number of shared co-authors 2
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 6
David Geffen School of Medicine, University of California los angeles
Career Start Year 2006
Number of shared co-authors 1
The Scripps Research Institute
Career Start Year 2004
Number of shared co-authors 0
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2001
Number of shared co-authors 4
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2001
Number of shared co-authors 7
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 8
Center for Biomedical Education and Research (ZBAF), Witten/Herdecke University
Career Start Year 1999
Number of shared co-authors 2
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 4
University of Cambridge
Career Start Year 1996
Number of shared co-authors 2
University of Arizona
Career Start Year 1996
Number of shared co-authors 7
Washington University School of Medicine
Career Start Year 1996
Number of shared co-authors 5
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 8
University of California Berkeley
Career Start Year 1993
Number of shared co-authors 0
University of California los angeles
Career Start Year 1992
Number of shared co-authors 3
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 4
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 1991
Number of shared co-authors 8
School of Public Health, University of California berkeley
Career Start Year 1990
Number of shared co-authors 2
Louisiana State University
Career Start Year 1987
Number of shared co-authors 7
Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University
Career Start Year 1987
Number of shared co-authors 0
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 1
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 0
Ben-Gurion University of the Negev
Career Start Year 1984
Number of shared co-authors 2
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 0
Institute of Industrial Science, The University of Tokyo
Career Start Year 1979
Number of shared co-authors 1
University of California san francisco
Career Start Year 1976
Number of shared co-authors 0
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 2
Vanderbilt University Medical Center
Career Start Year 1975
Number of shared co-authors 2
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 3
Stanford University School of Medicine
Career Start Year 1960
Number of shared co-authors 1

Collaborators

Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 50
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 27
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 14
Oregon Health and Science University
Co-authored papers 10
University of Alabama
Co-authored papers 4
Co-authored papers 3
Vaccine and Gene Therapy Institute, Oregon Health and Sciences University
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
School of Public Health, University of Alabama at Birmingham
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
The University of Alabama School of Medicine
Co-authored papers 2
Ann & Robert H. Lurie Children's Hospital of Chicago
Co-authored papers 2
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 2
University of Wisconsin School of Medicine and Public Health
Co-authored papers 2
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 2
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 2
Heersink School of Medicine, The University of Alabama at Birmingham
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
UK System Immunity Research Institute, Cardiff University
Co-authored papers 1
Case Western Reserve University School of Medicine
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of Washington
Co-authored papers 1
Yale Cancer Center and Smilow Cancer Hospital, Yale University School of Medicine
Co-authored papers 1